No Data
SIGA Technologies Says Japan's Pharmaceutical Regulator Approves Its Antiviral Treatment for Smallpox, MPox, Cowpox
Express News | SIGA Technologies Inc - Japan Biotechno Pharma to Supply Tepoxx to National Stockpile
Express News | Tepoxx (Tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
SIGA Technologies Shares Are Trading Lower After Interim Results From the STOMP Study Showed That Tecovirimat Did Not Improve the Time to Lesion Resolution Compared to Placebo in Adults With Mild to Moderate Clade II Mpox.
No Data
. Then again I’m not sure how far their product is in its development. One sec
